홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Morpholine → 4-(4,4-Difluorocyclohexyl)-3-{fluoro[4-(trifluoromethyl)phenyl]methyl}-5-[(4-methoxybenzyl)oxy]-7,7-dimethyl-2-{1-[5-(morpholin-4-yl)pyrimidin-2-yl]piperidin-4-yl}-5,6,7,8-tetrahydroquinoline

HRID 715895
인쇄

반응식

HRID 715895 반응식
Br[C:2]1[CH:3]=[N:4][C:5]([N:8]2[CH2:13][CH2:12][CH:11]([C:14]3[C:23]([CH:24]([F:35])[C:25]4[CH:30]=[CH:29][C:28]([C:31]([F:34])([F:33])[F:32])=[CH:27][CH:26]=4)=[C:22]([CH:36]4[CH2:41][CH2:40][C:39]([F:43])([F:42])[CH2:38][CH2:37]4)[C:21]4[CH:20]([O:44][CH2:45][C:46]5[CH:51]=[CH:50][C:49]([O:52][CH3:53])=[CH:48][CH:47]=5)[CH2:19][C:18]([CH3:55])([CH3:54])[CH2:17][C:16]=4[N:15]=3)[CH2:10][CH2:9]2)=[N:6][CH:7]=1.[NH:56]1[CH2:61][CH2:60][O:59][CH2:58][CH2:57]1.C(O[Na])(C)(C)C.C1(P(C2CCCCC2)C2C=CC=CC=2C2C(C(C)C)=CC(C(C)C)=CC=2C(C)C)CCCCC1>C1(C)C=CC=CC=1.C([O-])(=O)C.[Pd+2].C([O-])(=O)C.O.C(O)(C)(C)C>[F:42][C:39]1([F:43])[CH2:40][CH2:41][CH:36]([C:22]2[C:21]3[CH:20]([O:44][CH2:45][C:46]4[CH:47]=[CH:48][C:49]([O:52][CH3:53])=[CH:50][CH:51]=4)[CH2:19][C:18]([CH3:54])([CH3:55])[CH2:17][C:16]=3[N:15]=[C:14]([CH:11]3[CH2:10][CH2:9][N:8]([C:5]4[N:4]=[CH:3][C:2]([N:56]5[CH2:61][CH2:60][O:59][CH2:58][CH2:57]5)=[CH:7][N:6]=4)[CH2:13][CH2:12]3)[C:23]=2[CH:24]([F:35])[C:25]2[CH:26]=[CH:27][C:28]([C:31]([F:33])([F:32])[F:34])=[CH:29][CH:30]=2)[CH2:37][CH2:38]1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 4

HCID 8083MorpholineHCID 111557942-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 866824252-[1-(5-Bromopyrimidin-2-yl)piperidin-4-yl]-4-(4,4-difluorocyclohexyl)-3-{fluoro[4-(trifluoromethyl)phenyl]methyl}-5-[(4-methoxybenzyl)oxy]-7,7-dimethyl-5,6,7,8-tetrahydroquinolineHCID 178418730CID 70078

생성물 1

HCID 86682427
4-(4,4-Difluorocyclohexyl)-3-{fluoro[4-(trifluoromethyl)phenyl]methyl}-5-[(4-methoxybenzyl)oxy]-7,7-dimethyl-2-{1-[5-(morpholin-4-yl)pyrimidin-2-yl]piperidin-4-yl}-5,6,7,8-tetrahydroquinoline
수율 84%

시약·촉매·용매 4

HCID 167845palladium(II) acetate촉매HCID 962Water용매HCID 1140Toluene용매HCID 6386tert-Butanol용매

반응 조건

온도
110 °C

실험 절차

To a solution of 5.09 g (6.12 mmol) of (−)-2-[1-(5-Bromopyrimidin-2-yl)piperidin-4-yl]-4-(4,4-difluorocyclohexyl)-3-{fluoro[4-(trifluoromethyl)phenyl]methyl}-5-[(4-methoxybenzyl)oxy]-7,7-dimethyl-5,6,7,8-tetrahydroquinoline, which was prepared by a method similar to that of Reference Example 11, in 50 ml of toluene, 10 ml of tert-butanol, 1.6 ml (18 mmol) of morpholine, 1.73 g (18.0 mmol) of tert-butoxy sodium, 437 mg (0.917 mmol) of 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl and 107 mg (0.477 mmol) of palladium acetate were added under an argon gas atmosphere, and the reaction solution was stirred at 110° C. for 2.8 hours. After completion of the reaction, the reaction solution was poured into water and extracted with ethyl acetate. The organic layer was washed with saturated sodium chloride aqueous solution and then the solvent was distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography [n-hexane/ethyl acetate=8/2-7/3-6/4 (V/V)] and the fraction including the desired compound was concentrated under reduced pressure to provide 4.30 g of the title compound as a white solid (yield: 84%).

후처리

  1. customAfter completion of the reaction
  2. extractionextracted with ethyl acetate
  3. washThe organic layer was washed with saturated sodium chloride aqueous solution
  4. distillationthe solvent was distilled off under reduced pressure
  5. concentrationwas concentrated under reduced pressure

출처 및 근거

ORD 기록
ord-f8fa920c4aab4ce1a64c91b5d5d2fe9c
출처 데이터셋
uspto-grants-2015_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09187450B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트